产品编号：B675707
产品规格：10mg
产品价格：面议
| 标准品编号: | B675707 |
| 名称: | (1R,2R)-Bortezomib-d5 |
| 别名: | B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic-d5 Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic-d5 Acid; |
| 参考CAS: | 1132709-15-9 - Unlabelled |
| 分子式: | C₁₉H₂₀D₅BN₄O₄ |
| 分子量: | 389.27 |
| 类别: | Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Labelled (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway |
| 参考文献 | |
